Supriya
SUPRIYA.NSSupriya Lifescience Limited Price (SUPRIYA.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
80,482,800
(0)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Supriya Lifescience LimitedCurrency: INR
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
2.13B
+0% |
2.78B
+30% |
3.12B
+12% |
3.85B
+24% |
5.19B
+35% |
4.61B
-11% |
5.70B
+24% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 1.78B | 1.74B | 1.63B | 1.51B | 2.30B | 1.81B | 3.60B | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
350.97M
+0% |
1.04B
+197% |
1.49B
+43% |
2.34B
+57% |
2.89B
+24% |
2.80B
-3% |
2.11B
-25% |
||||||||||||
| Gross Profit Ratio | (0.16%) | (0.38%) | (0.48%) | (0.61%) | (0.56%) | (0.61%) | (0.37%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 7.06M | 7.78M | 10.57M | 6.61M | 16.62M | 12.37M | 10.85M | ||||||||||||
| General and Administrative | 162.96M | 69.50M | 104.80M | 105.17M | 137.32M | 192.26M | 231.87M | ||||||||||||
| Selling, General & Admin... | 166.47M | 183.22M | 240.18M | 336.37M | 361.07M | 430.93M | 463.67M | ||||||||||||
| Selling & Marketing Exp... | 67.27M | 113.72M | 135.38M | 231.20M | 223.75M | 238.67M | 231.80M | ||||||||||||
| Depreciation and Amortiz... | 53.32M | 54.35M | 64.05M | 67.61M | 101.18M | 118.15M | 158.11M | ||||||||||||
| Other Expenses | -10,530,000.00 | 48.14M | 83.55M | 39.69M | 110.00k | 94.89M | 6.06M | ||||||||||||
| Total Operating Expenses | 184.06M | 432.22M | 564.45M | 735.79M | 873.31M | 1.63B | 2.80B | ||||||||||||
| Cost and Exponses | 1.96B | 2.17B | 2.19B | 2.25B | 3.17B | 3.44B | 4.04B | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
166.91M
+0% |
610.98M
+266% |
1.01B
+65% |
1.66B
+65% |
2.04B
+23% |
1.17B
-43% |
1.57B
+34% |
||||||||||||
| Operating Income Ratio | (0.08%) | (0.22%) | (0.32%) | (0.43%) | (0.39%) | (0.25%) | (0.28%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 103.85M | 6.24M | 21.73M | 49.91M | 74.19M | 95.59M | 83.45M | ||||||||||||
| Interest Expenses | 0.00 | 102.22M | 68.49M | 40.80M | 28.11M | 30.84M | 37.03M | ||||||||||||
| Total Other Income/Exp... | -22,270,000.00 | -39,940,000.00 | -45,800,000.00 | 28.68M | 50.88M | -629,400,000.00 | 85.25M | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 266.81M | 724.67M | 1.09B | 1.78B | 2.22B | 1.38B | 1.84B | ||||||||||||
| EBITDA ratio | (0.10%) | (0.25%) | (0.35%) | (0.46%) | (0.42%) | (0.30%) | (0.32%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 144.64M | 571.04M | 962.27M | 1.67B | 2.07B | 1.23B | 1.66B | ||||||||||||
| Income Before Tax Ratio | (0.07%) | (0.21%) | (0.31%) | (0.43%) | (0.40%) | (0.27%) | (0.29%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 57.36M | 176.79M | 228.24M | 435.65M | 554.35M | 336.30M | 465.76M | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 87.28M
+0% |
394.24M
+352% |
734.03M
+86% |
1.24B
+68% |
1.52B
+23% |
898.57M
-41% |
1.19B
+33% |
||||||||||||
| Net Income Ratio | (0.04%) | (0.14%) | (0.24%) | (0.32%) | (0.29%) | (0.19%) | (0.21%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 1.19 | 15.43 | 10.03 | 16.89 | 18.86 | 11.16 | 14.80 | ||||||||||||
| Diluted EPS | 1.19 | 15.43 | 10.03 | 16.89 | 18.86 | 11.16 | 14.80 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 73.18M | 25.55M | 73.18M | 73.18M | 80.48M | 80.48M | 80.48M | ||||||||||||
| Diluted Share Outstanding | 73.18M | 25.55M | 73.18M | 73.18M | 80.48M | 80.48M | 80.48M | ||||||||||||